ReviewBMC pulmonary medicine2026

A rare immune-related adverse event of pleural effusion after tislelizumab for non-small cell lung cancer: a case report and literature review.

Meibin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.